Skip to main content

Table 2 Characteristics of the studied population: demographic data, diurnal and nocturnal gas exchanges and ventilator settings

From: Monitoring of noninvasive ventilation: comparative analysis of different strategies

Variables

OLD

CWD

NMD

Global population

Effective

25

29

46

100

 Anthropometric data

  Age (years)

70 [61–77]

71 [60–75]

50 [22–62]*¶

62 [47–71]

  Gender (male/female)

16/9

12/17

31/15

59/41

  BMI (kg/m2)

39 [32.2–41.5]

40 [27.2–47.7]

22 [18.4–30.5]*

31.0 [21.6–40.4]

 Daytime arterial blood gases

  Daytime PaO2 (mmHg)

66.5 [61.1–79.3]

65 [60.7–73]

78 [71–93]*¶

71.3 [62.4–84]

  Daytime PaCO2 (mmHg)

45 [41.9–49]

42 [39.3–47.8]

41 [38.5–44.2]*

41.9 [39.4–47]

 Nocturnal transcutaneous capnography

  Median SpO2 (%)

90 [89–92.4]

92 [89.8–93.3]

95 [93.8–96]*

93 [90–95]

  Median TcPCO2 (mmHg)

49 [44.2–53.2]

48 [43–52.4]

43 [40–47.3]*¶

45.8 [41.9–50.1]

  Maximal TcPCO2 (mmHg)

55 [49.5–64]

56 [52.5–59]

48 [44–53.5]*

52 [46–57]

  Recording time spent with TcPCO2 > 50 mmHg

58 [1.96–89.9]

28 [3.3–81.5]

0 [0–28.2]*

6.7 [0–72.1]

 Ventilator settings

  Inspiratory pressure (cmH2O)

19 [18–21]

18 [16–19]

16 [14–17]*¶

17.5 [16–19]

  Expiratory pressure (cmH2O)

8 [6–9]

9 [5–10]

6 [4–8]*¶

6 [4–10]

  Interface: nasal/oronasal mask

12/13

13/16

28/18*¶

53/47

  Compliance (h/day)

8.5 [7.5–10]

7.2 [5.8–9.7]

8 [6–9.4]

7.9 [6.1–9]

  1. Data are presented as median [first and third quartiles] or number of subjects
  2. BMI body mass index, CWD chest wall diseases, NIV noninvasive ventilation, NMD neuromuscular diseases, OLD obstructive lung diseases, PaCO2 arterial carbon dioxide partial pressure, PaO2 arterial dioxygen partial pressure SpO2 transcutaneous pulsed oxygen saturation, TcPCO2 transcutaneous carbon dioxide partial pressure
  3. * p < 0.05 for comparisons to OLD group
  4. ¶ p < 0.05 for comparisons to CWD group (Kruskall–Wallis test then Dunn’s post-hoc analysis or χ2)